Forsyth Medical Center
Forsyth Medical Center

Indication and Safety Information

FLUDEOXYGLUCOSE F 18 INJECTION, USP

For Intravenous Use 

 

INDICATIONS AND USAGE
Fludeoxyglucose F 18 injection (18F FDG) is indicated for positron emission tomography (PET) imaging in the following settings:

 

Oncology: For assessment of abnormal glucose metabolism to assist in the evaluation of malignancy in patients with known or suspected abnormalities found by other testing modalities, or in patients with an existing diagnosis of cancer.

 

Cardiology: For the identification of left ventricular myocardium with residual glucose metabolism and reversible loss of systolic function in patients with coronary artery disease and left ventricular dysfunction, when used together with myocardial perfusion imaging. 

 

Neurology: For the identification of regions of abnormal glucose metabolism associated with foci of epileptic seizures. 

 

IMPORTANT SAFETY INFORMATION
Radiation Risks: Radiation-emitting products, including fludeoxyglucose F 18 injection, may increase the risk for cancer, especially in pediatric patients. Use the smallest dose necessary for imaging and ensure safe handling to protect the patient and health care worker. 

 

Blood Glucose Abnormalities: In the oncology and neurology setting, suboptimal imaging may occur in patients with inadequately regulated blood glucose levels. In these patients, consider medical therapy and laboratory testing to assure at least two days of normoglycemia prior to fludeoxyglucose F18 injection administration. 

 

Adverse Reactions: Hypersensitivity reactions with pruritus, edema and rash have been reported; have emergency resuscitation equipment and personnel immediately available. Following the Scan

Once the PET/CT scan is complete, you will be able to leave the imaging facility. Make sure you drink plenty of water or other fluids throughout the day.

 

The results of your scan will be interpreted by a trained nuclear medicine physician or radiologist and your physician will receive a written report approximately 24 to 48 hours after completion of the study. 

Please contact your physician to discuss the results.

SODIUM FLUORIDE F 18 INJECTION

For Intravenous Use 

INDICATIONS AND USAGE 
Sodium Fluoride F 18 Injection is a radioactive diagnostic agent for positron emission tomography (PET) indicated for imaging of bone to define areas of altered osteogenic activity. 

IMPORTANT SAFETY INFORMATION 
Allergic Reactions: As with any injectable drug product, allergic reactions and anaphylaxis may occur. Emergency resuscitation equipment and personnel should be immediately available. 


Cancer Risk: Sodium Fluoride F 18 Injection may increase the risk of cancer. Use the smallest dose necessary for imaging and ensure safe handling to protect the patient and health care worker. 

Adverse Reactions: No adverse reactions have been reported for Sodium Fluoride F 18 Injection based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting system. 

Forsyth Medical Center

PET/CT Department

3333 Silas Creek Parkway

Winston-Salem, NC 27103

P - 336.718.2786

F - 336.718.9850

Hours

Monday - Friday

7 a.m. - 5 p.m.

Get connected

Print Print | Sitemap
© Forsyth Medical Center